Ticker Scorecard - PTGX Basics Company: Protagonist Therapeutics, Inc. IPO Date: August 11, 2016 Sector: Healthcare Industry: Biotech Market Cap: $2.31B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.90% Avg Daily Range (30 D): $0.64 | 1.69% Avg Daily Range (90 D): $0.79 | 1.90% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .41M Avg Daily Volume (90 D): .47M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 43 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 2,375 Avg Inst. Trade: $2.47M Avg Inst. Trade (30 D): $2.31M Avg Inst. Trade (90 D): $2.57M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.26M Avg Closing Trade (30 D): $3.57M Avg Closing Trade (90 D): $4.24M Avg Closing Volume: 141.5K     News Feb 20, 2025 @ 6:00 PM BESREMi Achieves Strong Market Growth Amid Rising ... Source: Delveinsight Feb 17, 2025 @ 5:57 PM Polycythemia Vera Market Insight, Epidemiology and... Source: Researchandmarkets.Com Apr 5, 2024 @ 4:00 PM All You Need to Know About Protagonist Therapeutic... Source: Zacks Equity Research Mar 18, 2024 @ 1:55 PM Wall Street Analysts Think Protagonist Therapeutic... Source: Zacks Equity Research Mar 15, 2024 @ 10:13 AM 4 Stocks to Buy for Attractive Earnings Accelerati... Source: Tirthankar Chakraborty Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.86 $-.54 $-.5 Diluted EPS $2.74 $-.54 $-.5 Revenue $ 323.8M $ 4.68M $ 4.17M Gross Profit $ $ $ Net Income / Loss $ 170.85M $ -33.21M $ -30.62M Operating Income / Loss $ 149.11M $ -41.45M $ -38.79M Cost of Revenue $ $ $ Net Cash Flow $ -99.41M $ -224.52M $ 183.08M PE Ratio 14.14